VYNE THERAPEUTICS INC
VYNE·92941V308·US·Common Stock·Healthcare - Biotechnology-13D/G
VYNE (VYNE THERAPEUTICS INC) is held by 21 institutional investors as of Q1 2026. Largest holders: CITADEL ADVISORS LLC ($307,380), TWO SIGMA INVESTMENTS, LP ($254,781), GEODE CAPITAL MANAGEMENT, LLC ($192,824). Net institutional sentiment: Bullish.
21
Holders
Avg rating(4 Elite)
$1.4M
Total Value
69% (24)
Fund Consensus
11 buying - 5 selling
Who's Trading
ActivistZXZhang XiaofanJul 14, 2026
ActivistZXZhang Xiaofan5.6%Jun 15, 2026
ActivistNANantahala Capital Management, LLC6.0%May 15, 2026
ActivistEAEventide Asset Management, LLC0.0%Nov 14, 2025
ActivistCACormorant Asset Management, LP0.0%Nov 14, 2025
13F: Insider & Congress:
Showing 1-20 of 24
1 / 2
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer